|4Sep 20, 4:57 PM ET

Farfel Gail M 4

4 · ProMIS Neurosciences Inc. · Filed Sep 20, 2022

Insider Transaction Report

Form 4
Period: 2022-09-19
Farfel Gail M
Chief Executive Officer
Transactions
  • Award

    Option (right to buy)

    2022-09-19+208,334208,334 total
    Exercise: $7.10Exp: 2032-09-19Common Shares (208,334 underlying)
Footnotes (2)
  • [F1]Conversion or exercise price is in Canadian dollars.
  • [F2]The option agreement provides that the option vests 25% on the one year anniversary of grant and the balance vests ratably over 36 months.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES